These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Substance P, a neuropeptide, inhibits measles virus replication in cell culture. Schroeder C Acta Virol; 1986 Sep; 30(5):432-5. PubMed ID: 2431610 [TBL] [Abstract][Full Text] [Related]
5. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology. Watanabe S; Ohno S; Shirogane Y; Suzuki SO; Koga R; Yanagi Y J Virol; 2015 Mar; 89(5):2710-7. PubMed ID: 25520515 [TBL] [Abstract][Full Text] [Related]
6. Antipeptide antibodies that recognize a lymphocyte substance P receptor. Pascual DW; Blalock JE; Bost KL J Immunol; 1989 Dec; 143(11):3697-702. PubMed ID: 2479686 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303 [TBL] [Abstract][Full Text] [Related]
9. A single amino acid substitution in the measles virus F₂ protein reciprocally modulates membrane fusion activity in pathogenic and oncolytic strains. Heidmeier S; Hanauer JR; Friedrich K; Prüfer S; Schneider IC; Buchholz CJ; Cichutek K; Mühlebach MD Virus Res; 2014 Feb; 180():43-8. PubMed ID: 24368277 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to the rat substance P receptor: production and characterization. Gilbert MS; Bunnett NW; Payan DG Cell Mol Neurobiol; 1992 Dec; 12(6):529-45. PubMed ID: 1283362 [TBL] [Abstract][Full Text] [Related]
11. Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. Payan DG; Brewster DR; Goetzl EJ J Immunol; 1984 Dec; 133(6):3260-5. PubMed ID: 6092469 [TBL] [Abstract][Full Text] [Related]
12. Measles virus targets DC-SIGN to enhance dendritic cell infection. de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615 [TBL] [Abstract][Full Text] [Related]
13. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355 [TBL] [Abstract][Full Text] [Related]
14. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Anderson BD; Nakamura T; Russell SJ; Peng KW Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464 [TBL] [Abstract][Full Text] [Related]
15. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung. Geraghty DP; Mussap CJ; Burcher E Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705 [TBL] [Abstract][Full Text] [Related]
16. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946 [TBL] [Abstract][Full Text] [Related]
17. Development of a biotinylated analog of substance P for use as a receptor probe. Anton PA; Reeve JR; Vidrich A; Mayer E; Shanahan F Lab Invest; 1991 May; 64(5):703-8. PubMed ID: 1709427 [TBL] [Abstract][Full Text] [Related]
18. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. Cathomen T; Mrkic B; Spehner D; Drillien R; Naef R; Pavlovic J; Aguzzi A; Billeter MA; Cattaneo R EMBO J; 1998 Jul; 17(14):3899-908. PubMed ID: 9670007 [TBL] [Abstract][Full Text] [Related]
19. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme. Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. Wild TF; Buckland R J Gen Virol; 1997 Jan; 78 ( Pt 1)():107-11. PubMed ID: 9010292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]